• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

更换Impella 5.0后清除系统故障风险增加:病例系列

Increased risk of purge system malfunction after Impella 5.0 replacement: a case series.

作者信息

Oishi Hideo, Morimoto Ryota, Ito Ryota, Kazama Shingo, Kimura Yuki, Araki Takashi, Mizutani Takashi, Kuwayama Tasuku, Hiraiwa Hiroaki, Kondo Toru, Okumura Takahiro, Mutsuga Masato, Usui Akihiko, Murohara Toyoaki

机构信息

Department of Cardiology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan.

Department of Cardiac Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan.

出版信息

J Artif Organs. 2023 Mar;26(1):79-83. doi: 10.1007/s10047-022-01337-0. Epub 2022 May 16.

DOI:10.1007/s10047-022-01337-0
PMID:35575950
Abstract

The Impella 5.0 is an axial-flow percutaneous ventricular assist device used in patients with cardiogenic shock. Although the recommended period of use is 10 days or less, weaning can be delayed because of ongoing hemodynamic instability. In clinical practice, this device sometimes malfunctions during long-term management with heparin and must be replaced; however, the relationship between the duration of support with the initial and replacement Impella 5.0 and the changes in value of the purge system has not been fully elucidated. From July 2018 to May 2021, Impella 5.0 was implanted and used for more than 10 days in 11 patients at our institution. Four patients required Impella replacement because of device malfunction and the second Impella had purge system malfunction in all cases. The second Impella was used for a significantly shorter time than the first Impella (p = 0016). We calculated the ratio of purge pressure to purge flow rate and found that the ratio exceeded 50 mm Hg/mL/h in all cases with purge system malfunction. In conclusion, it is important to construct a treatment strategy considering the duration of use, because the risk of purge system malfunction is high after replaced Impella 5.0.

摘要

Impella 5.0是一种用于心源性休克患者的轴流式经皮心室辅助装置。尽管推荐使用期限为10天或更短,但由于血流动力学持续不稳定,撤机可能会延迟。在临床实践中,该装置在长期肝素治疗期间有时会发生故障,必须进行更换;然而,最初的Impella 5.0和更换后的Impella 5.0的支持持续时间与冲洗系统值的变化之间的关系尚未完全阐明。2018年7月至2021年5月,我院11例患者植入Impella 5.0并使用超过10天。4例患者因装置故障需要更换Impella,所有病例中第二个Impella均出现冲洗系统故障。第二个Impella的使用时间明显短于第一个Impella(p = 0.016)。我们计算了冲洗压力与冲洗流速的比值,发现所有冲洗系统故障的病例中该比值均超过50 mmHg/mL/h。总之,考虑使用持续时间构建治疗策略很重要,因为更换Impella 5.0后冲洗系统故障的风险很高。

相似文献

1
Increased risk of purge system malfunction after Impella 5.0 replacement: a case series.更换Impella 5.0后清除系统故障风险增加:病例系列
J Artif Organs. 2023 Mar;26(1):79-83. doi: 10.1007/s10047-022-01337-0. Epub 2022 May 16.
2
Use of Sodium Bicarbonate Purge Solution in Impella Devices for Heparin-Induced Thrombocytopenia.碳酸氢钠冲洗液在用于肝素诱导的血小板减少症的Impella装置中的应用
J Pharm Pract. 2023 Aug;36(4):1035-1038. doi: 10.1177/08971900221089078. Epub 2022 Apr 7.
3
Analysis of Bicarbonate-Based Purge Solution in Patients With Cardiogenic Shock Supported Via Impella Ventricular Assist Device.心脏支持型 Impella 心室辅助装置中使用碳酸氢盐基冲洗液的患者分析。
Ann Pharmacother. 2023 Jun;57(6):646-652. doi: 10.1177/10600280221124156. Epub 2022 Sep 13.
4
A case series analysis of bicarbonate-based purge solution administration via Impella ventricular assist device.经 Impella 心室辅助装置给予碳酸氢盐为基础的灌洗液的病例系列分析。
Am J Health Syst Pharm. 2024 Feb 20;81(5):e115-e121. doi: 10.1093/ajhp/zxad278.
5
Effective anticoagulation for a percutaneous ventricular assist device using a heparin-based purge solution.使用基于肝素的冲洗液对经皮心室辅助装置进行有效的抗凝。
Ann Pharmacother. 2013 Oct;47(10):1364-7. doi: 10.1177/1060028013503623.
6
Anticoagulation with temporary Impella device in patients with heparin-induced thrombocytopenia: A case series.肝素诱导血小板减少症患者应用临时 Impella 装置抗凝治疗:病例系列研究。
Int J Artif Organs. 2021 May;44(5):367-370. doi: 10.1177/0391398820964810. Epub 2020 Oct 14.
7
The Impella device for acute mechanical circulatory support in patients in cardiogenic shock.Impella 装置在心源休克患者中的急性机械循环支持。
Ann Thorac Surg. 2014 Jan;97(1):133-8. doi: 10.1016/j.athoracsur.2013.07.053. Epub 2013 Oct 1.
8
Impella 5.0 Support in INTERMACS II Cardiogenic Shock Patients Using Right and Left Axillary Artery Access.在使用左右腋动脉入路的INTERMACS II级心源性休克患者中使用Impella 5.0支持
Artif Organs. 2015 Aug;39(8):660-3. doi: 10.1111/aor.12529. Epub 2015 Jul 6.
9
Use of an argatroban-based purge solution in a percutaneous ventricular assist device.基于阿加曲班的冲洗液在经皮心室辅助装置中的应用。
Am J Health Syst Pharm. 2017 May 1;74(9):e163-e169. doi: 10.2146/ajhp160212.
10
Adding an extension piece to the end of the purge side arm of the Impella device can prevent the incidence of the cassette breaking and decrease the Impella device failure rate: Impact of practice change on patient outcome.在 Impella 装置的清洗侧臂末端添加延伸件可以防止盒式部件断裂,并降低 Impella 装置的故障发生率:实践改变对患者预后的影响。
Perfusion. 2024 Nov;39(8):1757-1760. doi: 10.1177/02676591231220305. Epub 2023 Dec 7.

引用本文的文献

1
The Role of Ventricular Assist Devices in Patients With Heart Failure Due to Dilated Cardiomyopathy: A Systematic Review.心室辅助装置在扩张型心肌病所致心力衰竭患者中的作用:一项系统评价
Cureus. 2024 Aug 6;16(8):e66259. doi: 10.7759/cureus.66259. eCollection 2024 Aug.
2
Usefulness of bicarbonate-based Impella purge solution in a patient with heparin-induced thrombocytopenia: the first case report of long-term management in Japan.基于碳酸氢盐的Impella冲洗液在肝素诱导的血小板减少症患者中的应用:日本首例长期管理病例报告
J Artif Organs. 2025 Mar;28(1):83-89. doi: 10.1007/s10047-024-01452-0. Epub 2024 Jun 6.

本文引用的文献

1
Percutaneous thrombectomy of Impella-associated iliac artery thrombosis using the FlowTriever system.使用FlowTriever系统对Impella相关的髂动脉血栓进行经皮血栓切除术。
Clin Case Rep. 2020 Aug 18;8(12):2645-2649. doi: 10.1002/ccr3.3226. eCollection 2020 Dec.
2
Surgical transaxillary placement of the Impella 5.0 ventricular assist device.经腋路手术植入Impella 5.0心室辅助装置。
J Card Surg. 2019 Feb;34(2):92-98. doi: 10.1111/jocs.13978. Epub 2019 Jan 9.
3
Outcomes of Impella 5.0 in Cardiogenic Shock: A Systematic Review and Meta-analysis.
Impella 5.0用于心源性休克的疗效:一项系统评价和荟萃分析。
Innovations (Phila). 2018 Jul/Aug;13(4):254-260. doi: 10.1097/IMI.0000000000000535.
4
Caliber and fitness of the axillary artery as a conduit for large-bore cardiovascular procedures.作为大口径心血管手术管道的腋动脉的管径和适用性。
Catheter Cardiovasc Interv. 2018 Jan 1;91(1):150-156. doi: 10.1002/ccd.27416. Epub 2017 Nov 11.
5
Effectiveness and Safety of the Impella 5.0 as a Bridge to Cardiac Transplantation or Durable Left Ventricular Assist Device.Impella 5.0作为心脏移植或持久性左心室辅助装置桥梁的有效性和安全性
Am J Cardiol. 2016 May 15;117(10):1622-1628. doi: 10.1016/j.amjcard.2016.02.038. Epub 2016 Mar 4.
6
Impella 5.0 Support in INTERMACS II Cardiogenic Shock Patients Using Right and Left Axillary Artery Access.在使用左右腋动脉入路的INTERMACS II级心源性休克患者中使用Impella 5.0支持
Artif Organs. 2015 Aug;39(8):660-3. doi: 10.1111/aor.12529. Epub 2015 Jul 6.